| Interferon-γ: an overview of signals, mechanisms and functions K Schroder, PJ Hertzog, T Ravasi, DA Hume Journal of Leucocyte Biology 75 (2), 163-189, 2004 | 5744 | 2004 |
| SOCS1 is a critical inhibitor of interferon γ signaling and prevents the potentially fatal neonatal actions of this cytokine WS Alexander, R Starr, JE Fenner, CL Scott, E Handman, NS Sprigg, ... Cell 98 (5), 597-608, 1999 | 967 | 1999 |
| Interferome v2. 0: an updated database of annotated interferon-regulated genes I Rusinova, S Forster, S Yu, A Kannan, M Masse, H Cumming, ... Nucleic acids research 41 (D1), D1040-D1046, 2012 | 940 | 2012 |
| Antitumour actions of interferons: implications for cancer therapy BS Parker, J Rautela, PJ Hertzog Nature Reviews Cancer 16 (3), 131-144, 2016 | 908 | 2016 |
| Type I IFNs enhance the terminal differentiation of dendritic cells T Luft, KC Pang, E Thomas, P Hertzog, DNJ Hart, J Trapani, J Cebon The Journal of Immunology 161 (4), 1947-1953, 1998 | 811 | 1998 |
| Suppressor of cytokine signaling 1 negatively regulates Toll-like receptor signaling by mediating Mal degradation A Mansell, R Smith, SL Doyle, P Gray, JE Fenner, PJ Crack, SE Nicholson, ... Nature immunology 7 (2), 148-155, 2006 | 671 | 2006 |
| Differential production of IL-12, IFN-α, and IFN-γ by mouse dendritic cell subsets H Hochrein, K Shortman, D Vremec, B Scott, P Hertzog, M O’Keeffe The Journal of Immunology 166 (9), 5448-5455, 2001 | 664 | 2001 |
| Cathepsin K knockout mice develop osteopetrosis due to a deficit in matrix degradation but not demineralization M Gowen, F Lazner, R Dodds, R Kapadia, J Feild, M Tavaria, I Bertoncello, ... Journal of bone and mineral research 14 (10), 1654-1663, 1999 | 636 | 1999 |
| Mice with a homozygous null mutation for the most abundant glutathione peroxidase, Gpx1, show increased susceptibility to the oxidative stress-inducing agents paraquat and … JB de Haan, C Bladier, P Griffiths, M Kelner, RD O'Shea, NS Cheung, ... Journal of Biological Chemistry 273 (35), 22528-22536, 1998 | 611 | 1998 |
| The vaccine adjuvant chitosan promotes cellular immunity via DNA sensor cGAS-STING-dependent induction of type I interferons EC Carroll, L Jin, A Mori, N Munoz-Wolf, E Oleszycka, HBT Moran, ... Immunity 44 (3), 597-608, 2016 | 558 | 2016 |
| Type I interferon receptors: biochemistry and biological functions NA De Weerd, SA Samarajiwa, PJ Hertzog Journal of Biological Chemistry 282 (28), 20053-20057, 2007 | 542 | 2007 |
| Silencing of Irf7 pathways in breast cancer cells promotes bone metastasis through immune escape BN Bidwell, CY Slaney, NP Withana, S Forster, Y Cao, S Loi, D Andrews, ... Nature medicine 18 (8), 1224-1231, 2012 | 540 | 2012 |
| Analysis of microRNA turnover in mammalian cells following Dicer1 ablation MP Gantier, CE McCoy, I Rusinova, D Saulep, D Wang, D Xu, AT Irving, ... Nucleic acids research 39 (13), 5692-5703, 2011 | 513 | 2011 |
| Mouse Plasmacytoid Cells: Long-lived Cells, Heterogeneous in Surface Phenotype and Function, that Differentiate Into CD8+ Dendritic Cells Only after Microbial … M O'Keeffe, H Hochrein, D Vremec, I Caminschi, JL Miller, EM Anders, ... The Journal of experimental medicine 196 (10), 1307-1319, 2002 | 511 | 2002 |
| A null mutation in the gene encoding a type I interferon receptor component eliminates antiproliferative and antiviral responses to interferons alpha and beta and alters … SY Hwang, PJ Hertzog, KA Holland, SH Sumarsono, MJ Tymms, ... Proceedings of the National Academy of Sciences 92 (24), 11284-11288, 1995 | 498 | 1995 |
| Bacterial membrane vesicles deliver peptidoglycan to NOD1 in epithelial cells M Kaparakis, L Turnbull, L Carneiro, S Firth, HA Coleman, HC Parkington, ... Cellular microbiology 12 (3), 372-385, 2010 | 482 | 2010 |
| STAT3 and STAT1 mediate IL-11–dependent and inflammation-associated gastric tumorigenesis in gp130 receptor mutant mice M Ernst, M Najdovska, D Grail, T Lundgren-May, M Buchert, H Tye, ... The Journal of clinical investigation 118 (5), 1727-1738, 2008 | 413 | 2008 |
| Type I IFN contributes to NK cell homeostasis, activation, and antitumor function JB Swann, Y Hayakawa, N Zerafa, KCF Sheehan, B Scott, RD Schreiber, ... The Journal of Immunology 178 (12), 7540-7549, 2007 | 390 | 2007 |
| Suppressor of cytokine signaling 1 regulates the immune response to infection by a unique inhibition of type I interferon activity JE Fenner, R Starr, AL Cornish, JG Zhang, D Metcalf, RD Schreiber, ... Nature immunology 7 (1), 33-39, 2006 | 373 | 2006 |
| GM-CSF-and M-CSF-dependent macrophage phenotypes display differential dependence on type I interferon signaling AJ Fleetwood, H Dinh, AD Cook, PJ Hertzog, JA Hamilton Journal of leukocyte biology 86 (2), 411-421, 2009 | 372 | 2009 |